Skip to main content
NIH funding notice PAR-18-657

Countermeasures Against Chemical Threats (CounterACT) Research Centers of Excellence (U54 Clinical Trial Optional)

Closed on October 8, 2020.

Posted
February 13, 2018
Close date
October 8, 2020
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

3 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $8,615,315 in first-year total cost, median $2,786,961.

Most frequent study sections

  1. Special Emphasis Panel[ZRG1 MDCN-B (54)]3

Most frequent institutions

  1. BRIGHAM AND WOMEN'S HOSPITAL1
  2. NORTHWESTERN UNIVERSITY AT CHICAGO1
  3. RBHS-SCHOOL OF PUBLIC HEALTH1
Competing awards under PAR-18-657 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2021Barrier Damage and The Immune CascadeNorthwestern University CounterACT Center of Excellence (NUCCX)1U54AR079795-01LAVKER, ROBERT MLU, KURTNORTHWESTERN UNIVERSITY AT CHICAGO, IL$2,786,961ZRG1
2021Rutgers University CounterACT Center of Excellence2U54AR055073-16LASKIN, JEFFREY DRBHS-SCHOOL OF PUBLIC HEALTH, NJ$2,578,396ZRG1
2019Advancing novel cyanide countermeasures1U54NS112107-01MACRAE, CALUM A.PETERSON, RANDALL TBRIGHAM AND WOMEN'S HOSPITAL, MA$3,249,958ZRG1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.